The priming effect of halogenated phospholipids on the functional responses of human neutrophils

Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology

Volumn 4, Issue 3, 2010, Pages 262-271

  Gorudko, I V ^a   Vakhrusheva, T V ^b   Mukhortova, A V ^a   Cherenkevich, S N ^a   Timoshenko, A V ^c   Sergienko, V I ^b   Panasenko, O M ^b  

^a BELARUSIAN STATE UNIVERSITY   (Belarus)

^b FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Aggregation; Degranulation; H 2O2 generation; Halogenated phospholipids; Myeloperoxidase; Neutrophils; Priming

Indexed keywords

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HALOGENATED PHOSPHOLIPID; HYDROGEN PEROXIDE; LECTIN; LIPOSOME; MYELOPEROXIDASE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGRANULATION; ENZYME RELEASE; EXOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE AGGREGATION; LEUKOCYTE FUNCTION; PRIORITY JOURNAL; UPREGULATION;

SOLANUM TUBEROSUM;

EID: 78651520491     PISSN: 19907478     EISSN: 19907494     Source Type: Journal    
DOI: 10.1134/S1990747810030037     Document Type: Article

References (54)

1. Dale D. C., Boxer L., Liles W. C. 2008. The phagocytes: neutrophils and monocytes. Blood. 112, 935-945.
2. Klebanoff S. J. 2005. Myeloperoxidase: Friend and foe. J. Leukoc. Biol. 77, 598-625.
3. Baldus S., Heeschen C, Meinertz T., Zeiher A. M., Eiserich J. P., Münzel T., Simoons M. L., Hamm C. W. 2003. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 108, 1440-1445.
4. Klebanoff S. J. 1968. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J. Bacteriol. 95, 2131-2138.
5. Zemskov V. M. 1984. Phagocytosis: Physiological and molecular aspects. Uspekhi sovremennoy biologii (Rus.). 98, 219-233.
6. Midwinter R. G., Vissers M. C., Winterbourn C. C. 2001. Hypochlorous acid stimulation of the mitogenactivated protein kinase pathway enhances cell survival. Arch. Biochem. Biophys. 394, 13-20.
7. Vile G. F., Rothwell L. A., Kettle A. J. 1998. Hypochlorous acid activates the tumor suppressor protein p53 in cultured human skin fibroblasts. Arch. Biochem. Biophys. 359, 51-56.
8. Fu X., Kao J. L. F, Bergt C, Kassim S. Y, Huq N. P., d'Avignon A, Parks WC., Mecham RP., Heinecke J. W. 2004. Oxidative cross-linking of tryptophan to glycine restrains matrix metalloproteinase activity: specific structural motifs control protein oxidation. J. Biol. Chem. 279, 6209-6212.
9. Nguyen-Khoa T., Massy Z. A., Witko-Sarsat V., Canteloup S., Kebede M., Lacour B., Drueke T., Descamps-Latscha B. 1999. Oxidized low-density lipoprotein induces macrophage respiratory burst via its protein moiety: A novel pathway in atherogenesis? Biochem. Biophys. Res. Commun. 263, 804-809.
10. Kopprasch S., Leonhardt W., Pietzsch J., Kuhne H. 1998. Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells. Atherosclerosis. 136, 315-324.
11. Kopprasch S., Pietzsch J., Westendorf T., Kruse H. J., Grassler J. 2004. The pivotal role of scavenger receptor CD36 and phagocyte-derived oxidants in oxidized low density lipoprotein-induced adhesion to endothelial cells. Int. J. Biochem. Cell Biol. 36, 460-471.
12. Vicca S., Massy Z. A., Hennequin C., Rihane D., Drueke T. B., Lacour B. 2003. Apoptotic pathways involved in U937 cells exposed to LDL oxidized by hypochlorous acid. Free Radic. Biol. Med. 35, 603-615.
13. Arnhold J., Osipov AN., Spalteholz H., Panasenko O. M., Schiller J. 2001. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic. Biol. Med. 31, 1111-1119.
14. - system with unsaturated phosphatidylcholine. Biokhimiya (Rus.). 67, 1071-1084 (Pubitemid 35311833)
15. [Translated version: Biochemistry (Moscow). 67, 889-900].
16. Dever G. J., Benson R., Wainwright C. L., Kennedy S., Spickett CM. 2008. Phospholipid chlorohydrin induces leukocyte adhesion to ApoE-/-mouse arteries via upregulation of P-selectin. Free Radic. Biol. Med. 44, 452-463.
17. Messner M. C., Albert C. J., McHowat J., Ford D. A. 2008. Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions. Lipids. 43, 243-249.
18. Morris J. C. 1966. The acid ionization constant of HOCl from 5°C to 35°C. J. Phys. Chem. 70, 3798-3805.
19. Kumar K., Margerum D. W. 1987. Kinetics and mechanism of general-acid-assisted oxidation of bromide by hypochlorite and hypochlorous acid. Inorg. Chem. 26, 2706-2711.
20. 3, HOBr, and OBr2: Formation of bromochloramines. Inorg. Chem. 33, 118-123.
21. 2 and granule enzyme release from cells. Meth. Mol. Med. 9, 441-445.
22. 2 generation and aggregation of human neutrophils as affected by lectins. Gematol. Transfuziol. 40, 32-35.
23. Timoshenko A. V, Zorin V. P., Cherenkevich S. N. 1986. The influence of prostaglandins and inhibitors of arachidonic acid metabolism on Con A-induced agglutination of thymocytes. Abstracts of the All-Russian Symposium Synthesis and Analysis of Prostaglandins, Tallin, p. 169.
24. Timoshenko A. V., Fomichev A. Yu., Cherenkevich S. N. 1994. The effect of metabolic inhibitors on stability of mannose-specific contacts of Escherichia coli K12 and human neutrophils. Gen. Mikrobiol. Virusol. 5, 9-13.
25. Timoshenko A. V., Gorudko I. V., Cherenkevich S. N., Gabius H. J. 1999. Differential potency of two crosslinking plant lectins to induce formation of haptenic-sugar-resistant aggregates of rat thymocytes by post-binding signaling. FEBS Lett. 449, 75-78.
26. Schiller J., Arnhold J., Benard S., Müller M., Reichl S., Arnold K. 1999. Lipid analysis by matrix-assisted laser desorption and ionization mass spectrometry: A methodological approach. Anal. Biochem. 267, 46-56.
27. Timoshenko A. V., Cherenkevich S. N., Samal A. B. 1986. The role of reactive oxygen species in concanavallin A-induced agglutination of lymphocytes. Vestn. Belorusskogo universiteta. Series 2, Chemistry, Biology, Geography, no. 3, 47-50.
28. Lee S., Chung J., Ha I. S., Yi K., Lee J. E., Kang H. G., Choi I., Oh K.-H., Kim J. Y, Surh CD., Ahn C. 2007. Hydrogen peroxide increases human leukocyte adhesion to porcine aortic endothelial cells via NFkB-dependent up-regulation of VCAM-1. Int. Immunol. 19, 1349-1359.
29. Nicholls S. J., Hazen S. L. 2009. Myeloperoxidase, modified lipoproteins and atherogenesis. J. Lipid Res. Suppl. 50, Suppl., S346-S351.
30. Esterbauer H., Wäg G., Puhl H. 1993. Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull. 49, 566-576.
31. 2-isoprostanes. Circulation. 106, 2434-2441.
32. Dianzani C., Parrini M., Ferrara C., Fantozzi R. 1996. Effect of 4-hydroxynonenal on superoxide anion production from primed human neutrophils. Cell Biochem. Funct. 14, 193-200.
33. Sethi S., Eastman A. Y., Eaton J. W. 1996. Inhibition of phagocyte-endothelium interactions by oxidized fatty acids: A natural anti-inflammatory mechanism? J. Lab. Clin. Med. 128, 27-38.
34. Chen R., Chen X., Salomon R. G., McIntyre T. M. 2009. Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor. Arterioscler. Thromb. Vasc. Biol. 29, 363-371.
35. Leitinger N., Tyner T. R., Oslund L., Rizza C., Subbanagounder G., Lee H., Shih P. T., Mackman N., Tigyi G., Territo M. C., Berliner J. A., Vora D. K. 1999. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl. Acad. Sci. USA. 96, 12 010-12015.
36. Rouhanizadeh M., Hwang J., Clempus RE., Marcu L., Lassegue B., Sevanian A., Hsiai T. K. 2005. Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3- phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase. Free Radic. Biol. Med. 39, 1512-1522.
37. Malle E., Marsche G., Arnhold J., Davies M. J. 2006. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim. Biophys. Acta. 1761, 392-415.
38. Panasenko O. M., Vakhrusheva TV., Vlasova I. I., Chekanov A. V., Baranov Yu. V., Sergienko V. I. 2007. Role of myeloperoxidase-mediated modification of human blood lipoproteins in atherosclerosis development. Bull. Exp. Biol. Med. 144, 428-431.
39. Panasenko O. M., Spalteholz H., Schiller J., Arnhold J. 2003. Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines. Free Radic. Biol. Med. 34, 553-562.
40. Panasenko O. M., Spalteholz H., Schiller J., Arnhold J. 2006. Leukocytic myeloperoxidase-mediated formation of bromohydrins and lysophospholipids from unsaturated phosphatidylcholines. Biokhimiya (Rus.). 71, 707-718
41. [Translated version: Biochemistry (Moscow). 71, 571-580].
42. Condliffe A. M., Kitchen E., Chilvers E. R. 1998. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin. Sci. 94, 461-471.
43. Swain S. D., Rohn T. T., Quinn M. T 2002. Neutrophil priming in host defense: Role of oxidants as priming agents. Antioxid. Redox Signal. 4, 69-83.
44. Spickett CM. 2007. Chlorinated lipids and fatty acids: an emerging role in pathology. Pharmacol. Ther. 115, 400-409.
45. Dever G., Wainwright C. L., Kennedy S., Spickett, CM. 2006. Fatty acid and phospholipid chlorohydrins cause cell stress and endothelial adhesion. Acta Biochim. Pol. 53, 761-768.
46. Marsche G., Heller R., Fauler G., Kovacevic, A., Nuszkowski A., Graier W., Sattler W., Malle E. 2004. 2-Chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis. Arterioscler. Thromb. Vasc. Biol. 24, 2302-2306.
47. Podrez E. A., Poliakov E., Shen Z., Zhang R., Deng Y., Sun M., Finton P. J., Shan L., Gugiu B., Fox PL., Hoff H. F., Salomon R. G., Hazen S. L. 2002. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 277, 38503-38516.
48. Moore K. J., Freeman M. W. 2006. Scavenger receptors in atherosclerosis: Beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 26, 1702-1711.
49. Moumtzi A., Trenker M., Flicker K., Zenzmaier E., Saf R., Hermetter A. 2007. Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells. J. Lipid Res. 48, 565-582.
50. Rhode S., Grurl R., Brameshuber M., Hermetter A., Schütz G. J. 2009. Plasma membrane fluidity affects transient immobilization of oxidized phospholipids in endocytotic sites for subsequent uptake. J. Biol. Chem. 284, 2258-2265.
51. Shao D., Segal A. W., Dekker L. V. 2003. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett. 550, 101-106.
52. Sitrin R. G., Emery S. L., Sassanella T. M., Blackwood R. A., Petty H. R. 2006. Selective localization of recognition complexes for leukotriene B4 and formyl-Met-Leu-Phe within lipid raft microdomains of human polymorphonuclear neutrophils. J. Immunol. 177, 8177-8184.
53. Carr A. C., Vissers M. C., Domigan N. M., Winterbourn C. C. 1997. Modification of red cell membrane lipids by hypochlorous acid and haemolysis by preformed lipid chlorohydrins. Redox Rep. 3, 263-271.
54. Gorudko I. V., Buko I. V., Cherenkevich S. N., Polonetsky L. Z., Timoshenko A. V. 2008. Lectin-induced aggregates of blood cells from patients with acute coronary syndromes. Arch. Med. Res. 39, 674-681.